サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1790233

HSV検査の市場規模、シェア、動向分析：タイプ別、検査タイプ別、サンプルタイプ別、最終用途別、地域別、セグメント予測、2025年～2033年

HSV Testing Market Size, Share & Trends Analysis By Type, By Test Type, By Sample Type, By End-use, By Region, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
HSV検査の市場規模、シェア、動向分析：タイプ別、検査タイプ別、サンプルタイプ別、最終用途別、地域別、セグメント予測、2025年～2033年
出版日: 2025年07月28日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

HSV検査市場の概要

世界のHSV検査市場規模は、2024年に6億1,197万米ドルと推定され、2025～2033年にかけてCAGR 5.96%で成長し、2033年には10億1,775万米ドルに達すると予測されています。この市場には、単純ヘルペスウイルス1型と2型のタイムリーで信頼性の高い検出を目的とした診断ソリューションが含まれます。

このセグメントの検査プラットフォームは、伝統的血清学的手法から先進的な分子アッセイまで多岐にわたり、多様なヘルスケア環境における臨床判断をサポートします。これらのソリューションは、主に性感染症の管理や出生前スクリーニングに利用されており、分散型やポイントオブケアでの採用が拡大しています。単純ヘルペスウイルス感染症の罹患率が上昇していることに加え、国民の意識が高まり、性的健康スクリーニングを改善する取り組みが市場拡大を支えています。HSV検査とデジタルプラットフォームや遠隔診断ツールの統合は、特に低資源で十分な医療を受けられない環境における医療へのアクセスをさらに拡大し、早期発見とタイムリーな臨床介入を可能にしています。

分子診断技術の継続的な進歩により、HSV検査の感度と所要時間が向上しています。他の性感染病原体とともにHSVを検出できるマルチプレックスPCRプラットフォームは、特に外来患者や救急医療の現場で臨床的に好まれるようになってきています。さらに、検体から回答までのワークフローを改善した新しい検査キットの規制当局の承認は、プライマリケアや緊急医療の現場での使用をサポートしています。

STIサーベイランスと予防プログラムに対する政府の取り組みや資金の増加も市場の成長に寄与しています。公衆衛生キャンペーン、特に思春期と生殖の健康を対象にしたキャンペーンは、利用しやすく正確なHSV検査の需要を促進しています。公衆衛生機関と民間診断プロバイダとの開発協力により、より広範な検査利用が可能になり、先進国と資源が限られた地域における診断格差の縮小に役立っています。

目次

第1章 HSV検査市場：調査手法と範囲

第2章 HSV検査市場：エグゼクティブサマリー

  • 市場スナップショット
  • タイプとテストタイプのスナップショット
  • サンプルタイプのスナップショット
  • 最終用途スナップショット
  • 競合情勢のスナップショット

第3章 HSV検査市場の変数、動向、範囲

  • 市場セグメンテーションと範囲
  • 市場系統の展望
    • 親市場の展望
    • 関連/補助市場展望
  • 市場力学
  • 市場促進要因分析
    • 世界中でHSV感染率が上昇
    • 分子検査とポイントオブケア検査技術の進歩
    • 公衆衛生イニシアチブと定期的な性感染症検査プログラム
  • 市場抑制要因分析
    • 血清学的検査の診断精度の限界
    • HSV感染に関連するスティグマと報告不足
  • ポーターのファイブフォース分析
  • PESTLE分析
  • パイプライン分析

第4章 HSV検査市場：タイプ別、推定・動向分析

  • HSV検査市場：タイプ変動分析
  • HSV-1/HSV-2の混合
  • HSV-1
  • HSV-2

第5章 HSV検査市場：検査タイプ別、推定・動向分析

  • HSV検査市場：検査タイプ変動分析
  • 血清学的検査
  • 直接検出テスト
    • PCR
    • ウイルス培養
  • ポイントオブケア検査

第6章 HSV検査市場：サンプルタイプ別、推定・動向分析

  • HSV検査市場：サンプルタイプ変動分析
  • 血液
  • 綿棒
  • 脳脊髄液

第7章 HSV検査市場：最終用途別、推定・動向分析

  • HSV検査市場：最終用途変動分析
  • 病院
  • 診断ラボ
  • クリニックと性健康センター
  • 在宅医療/セルフテスト

第8章 HSV検査市場：地域ビジネス分析

  • 地域市場のスナップショット
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

  • 企業分類
  • 戦略マッピング
    • 新製品発売
    • パートナーシップ
    • 取得
    • コラボレーション
    • 資金調達
  • 主要企業の市場シェア分析（2024年）
  • 企業ヒートマップ分析
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • Abbott
    • Thermo Fisher Scientific Inc.
    • BD
    • Bio-Rad Laboratories, Inc.
    • BIOMERIEUX
    • DiaSorin SpA
    • Hologic, Inc.
    • Cepheid
    • QuidelOrtho Corporation
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global HSV Testing Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global HSV Testing Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 5 Global HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 6 Global HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 7 Global HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 North America HSV Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America HSV Testing Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 10 North America HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 11 North America HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 12 North America HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 14 U.S. HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 15 U.S. HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 16 U.S. HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada HSV Testing Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 18 Canada HSV Testing Market, by Type, 2021 - 2033 (USD Million)
  • Table 19 Canada HSV Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 20 Canada HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 22 Mexico HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 23 Mexico HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 24 Mexico HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe HSV Testing Market, by country, 2021 - 2033 (USD Million)
  • Table 26 Europe HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 27 Europe HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 28 Europe HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 29 Europe HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 31 UK HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 32 UK HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 33 UK HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 35 Germany HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 36 Germany HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 37 Germany HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 39 France HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 40 France HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 41 France HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 43 Italy HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 44 Italy HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 45 Italy HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 47 Spain HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 48 Spain HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 49 Spain HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Sweden HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 51 Sweden HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 52 Sweden HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 53 Sweden HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Norway HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 55 Norway HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 56 Norway HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 57 Norway HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 59 Denmark HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 60 Denmark HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 61 Denmark HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific HSV Testing Market, by country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 68 Japan HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 69 Japan HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 70 Japan HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 72 China HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 73 China HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 74 China HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 76 India HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 77 India HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 78 India HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 80 Australia HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 81 Australia HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 82 Australia HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 84 Thailand HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 85 Thailand HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 86 Thailand HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 88 South Korea HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 89 South Korea HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 90 South Korea HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America HSV Testing Market, by country, 2021 - 2033 (USD Million)
  • Table 92 Latin America HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 93 Latin America HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 94 Latin America HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 95 Latin America HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 97 Brazil HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 98 Brazil HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 99 Brazil HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 101 Argentina HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 102 Argentina HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 103 Argentina HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 MEA HSV Testing Market, by country, 2021 - 2033 (USD Million)
  • Table 105 MEA HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 106 MEA HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 107 MEA HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 108 MEA HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 110 South Africa HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 111 South Africa HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 112 South Africa HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 118 UAE HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 119 UAE HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 120 UAE HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait HSV Testing Market, by Sample Type, 2021 - 2033 (USD)
  • Table 122 Kuwait HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 123 Kuwait HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 124 Kuwait HSV Testing Market, By End Use, 32021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global HSV Testing market- Key market driver analysis
  • Fig. 7 Global HSV Testing market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global HSV Testing market - Porter's analysis
  • Fig. 10 Global HSV Testing market - PESTEL analysis
  • Fig. 11 Global HSV Testing market Type outlook key takeaways
  • Fig. 12 Global HSV Testing market: Type movement analysis
  • Fig. 13 HSV-1/HSV-2 Combines market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 HSV-1 market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 HSV-2 market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Global HSV Testing market test type outlook key takeaways
  • Fig. 17 Global HSV Testing market: test type movement analysis
  • Fig. 18 Serological tests market estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Direct detection tests market estimates, 2021 - 2033 (USD Million)
  • Fig. 20 PCR market estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Viral culture market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Point-of-care tests market estimates, 2021 - 2033 (USD Million)
  • Fig. 23 Global HSV Testing market sample type outlook key takeaways
  • Fig. 24 Global HSV Testing market: sample type movement analysis
  • Fig. 25 Blood market estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Swabs market estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Cerebrospinal fluid market estimates, 2021 - 2033 (USD Million)
  • Fig. 28 Global HSV Testing market end use outlook key takeaways
  • Fig. 29 Global HSV Testing market: end use movement analysis
  • Fig. 30 Hospitals market estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Diagnostic laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 32 Clinics and sexual health centers market estimates, 2021 - 2033 (USD Million)
  • Fig. 33 Home care / self-Testing market estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 Global HSV Testing market: Regional movement analysis
  • Fig. 36 North America HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 38 Canada HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 39 Mexico HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 40 Europe HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 41 UK HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 42 Germany HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 43 France HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 44 Spain HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 45 Italy HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 46 Denmark HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 47 Sweden HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 48 Norway HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 49 Asia Pacific HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 50 Japan HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 51 China HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 52 India HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 53 South Korea HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 54 Australia HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 55 Thailand HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 56 Latin America HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 57 Brazil HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 58 Argentina HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 59 MEA HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 60 South Africa HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 61 Saudi Arabia HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 62 UAE HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 63 Kuwait HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 64 Strategy framework
目次
Product Code: GVR-4-68040-688-1

HSV Testing Market Summary

The global HSV testing market size was estimated at USD 611.97 million in 2024 and is expected to reach USD 1017.75 million by 2033, growing at a CAGR of 5.96% from 2025 to 2033. This market encompasses diagnostic solutions aimed at the timely and reliable detection of herpes simplex virus types 1 and 2.

Testing platforms in this space range from traditional serological methods to advanced molecular assays, supporting clinical decisions across diverse healthcare environments. These solutions are primarily utilized in managing sexually transmitted infections and prenatal screening, with growing adoption in decentralized and point-of-care settings. The rising incidence of herpes simplex virus infections, along with heightened public awareness and efforts to improve sexual health screening, is supporting market expansion. Integration of HSV testing with digital platforms and remote diagnostic tools is further expanding access to care, particularly in low-resource and underserved settings, enabling earlier detection and timely clinical intervention.

Ongoing advancements in molecular diagnostic technologies are enhancing the sensitivity and turnaround time of HSV testing. Multiplex PCR platforms capable of detecting HSV alongside other sexually transmitted pathogens are gaining clinical preference, particularly in outpatient and emergency care settings. In addition, regulatory approvals for newer test kits with improved sample-to-answer workflows support their use in primary and urgent care environments.

Increased government initiatives and funding for STI surveillance and prevention programs also contribute to market growth. Public health campaigns, especially those targeting adolescent and reproductive health, are driving demand for accessible and accurate HSV testing. Collaborations between public health agencies and private diagnostic providers enable broader test availability, helping reduce diagnostic gaps in developed and resource-limited regions.

Global HSV Testing Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global HSV testing market based on type, test type, sample type, end-use, and region:

  • Type Outlook (USD Million, 2021 - 2033)
  • HSV-1/HSV-2 Combines
  • HSV-1
  • HSV-2
  • Test Type Outlook (USD Million, 2021 - 2033)
  • Serological tests
  • Direct detection tests
    • PCR
    • Viral culture
  • Point-of-care tests
  • Sample Type Outlook (USD Million, 2021 - 2033)
  • Blood
  • Swabs
  • Cerebrospinal fluid
  • End-use Outlook (USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Clinics and Sexual Health Centers
  • Home care / Self-testing
  • Regional Outlook (USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. HSV Testing Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Type Segment
      • 1.1.1.2. Test Type Segment
      • 1.1.1.3. Sample Type segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. HSV Testing Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type and Test Type Snapshot
  • 2.3. Sample Type Snapshot
  • 2.4. End Use Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. HSV Testing Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising prevalence of HSV infections worldwide
    • 3.4.2. Advancements in molecular and point-of-care Testing technologies
    • 3.4.3. Public health initiatives and routine STI screening programs
  • 3.5. Market Restraint Analysis
    • 3.5.1. Limited diagnostic accuracy of serological tests
    • 3.5.2. Stigma and underreporting associated with HSV infections
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. HSV Testing Market: Type Estimates & Trend Analysis

  • 4.1. HSV Testing Market: Type Movement Analysis
  • 4.2. HSV-1/HSV-2 Combines
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. HSV-1
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. HSV-2
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. HSV Testing Market: Test Type Estimates & Trend Analysis

  • 5.1. HSV Testing Market: Test Type Movement Analysis
  • 5.2. Serological tests
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Direct detection tests
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. PCR
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Viral culture
      • 5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Point-of-care tests
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. HSV Testing Market: Sample Type Estimates & Trend Analysis

  • 6.1. HSV Testing Market: Sample Type Movement Analysis
  • 6.2. Blood
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Swabs
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Cerebrospinal fluid
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. HSV Testing Market: End Use Estimates & Trend Analysis

  • 7.1. HSV Testing Market: End Use Movement Analysis
  • 7.2. Hospitals
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Diagnostic Laboratories
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Clinics and sexual health centers
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Home care / self-testing
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. HSV Testing Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America HSV Testing Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Reimbursement Scenario
      • 8.2.2.5. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Reimbursement Scenario
      • 8.2.3.5. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Reimbursement Scenario
      • 8.2.4.5. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe HSV Testing Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Competitive Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Competitive Scenario
    • 8.3.4. Spain
      • 8.3.4.1. Spain HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Competitive Scenario
    • 8.3.5. France
      • 8.3.5.1. France HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Reimbursement Scenario
      • 8.3.5.5. Competitive Scenario
    • 8.3.6. Italy
      • 8.3.6.1. Italy HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Reimbursement Scenario
      • 8.3.6.5. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Reimbursement Scenario
      • 8.3.7.5. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Reimbursement Scenario
      • 8.3.8.5. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Reimbursement Scenario
      • 8.3.9.5. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific HSV Testing Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Competitive Scenario
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Competitive Scenario
    • 8.4.7. Australia
      • 8.4.7.1. Australia HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America HSV Testing Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA HSV Testing Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Scenario
      • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. NEW PRODUCT LAUNCH
    • 9.2.2. PARTNERSHIPS
    • 9.2.3. ACQUISITION
    • 9.2.4. COLLABORATION
    • 9.2.5. FUNDING
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Heat Map Analysis
  • 9.5. Company Profiles
    • 9.5.1. F. Hoffmann-La Roche Ltd.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Abbott
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Thermo Fisher Scientific Inc.
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. BD
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Bio-Rad Laboratories, Inc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. BIOMERIEUX
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. DiaSorin S.p.A.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Hologic, Inc.
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Cepheid
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. QuidelOrtho Corporation
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives